|
Elitek
Elitek
information and resources from the National Cancer Institute
Elitek
(Other name for: rasburicase)
Rasburicase
ELITEK is indicated for the initial management of plasma uric acid levels in pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.
Sanofi-Synthelabo, Inc Jul 12 2002
|
|
|
|
|
|
Elitek
-->
|
